BillionToOne, Inc. reiterated the full year 2025 guidance and initiated the full year 2026 guidance.
Full year 2026 total revenue projected to be $415 million to $430 million, with positive GAAP operating income.
Excitement for scaling their platform and solving clinical challenges expressed by Dr. Oguzhan Atay, Co-founder and CEO.
Full Year 2026 Total Revenue
$415 million to $430 million, growth of 40% to 45% compared to 2025 guidance.
Positive GAAP Operating Income
Expected for the full year 2026.
- BillionToOne aims to deepen its impact on healthcare through innovative science and disciplined execution.
- The company anticipates delivering a durable, high-quality growth profile in 2026.
With clear growth projections and a focus on healthcare impact, BillionToOne is poised for a successful year in 2026.